IGHE and allergic disease: Remarkably, doses ranging from 100 to 1000 mg/g of BW, administered intraperitoneally, led to a 100% inhibition of compound 48/80-induced allergic reactions, as well as significantly curtailed local allergic reactions triggered by anti-DNP IgE.